Changes in Office of Research
Several changes have taken place in the Office of Research since September 2004. Led by Sandra Degen, PhD, the Office of Research is responsible for the university's compliance programs in research, technology transfer and commercialization, the Office of Entrepreneurial Affairs, and Laboratory Animal Medicine Services. Currently, a search is under way for a permanent Compliance and Regulatory Affairs Officer, and a new Web site is in development for the Office of Research. In addition, the Offices of Sponsored Programs (East and West) have merged into one Office of Sponsored Programs, which will serve the entire university research enterprise. This combined office will report directly to Bob Ambach, associate senior vice president for finance and administration. View the official Office of Research announcement.
UC Scientist Wins Parkinson's Research Award
Kim Seroogy, PhD, professor in the Department of Neurology, has received a $250,000 grant from the Michael J. Fox Foundation's 2004 Community Fast Track Program. Dr. Seroogy's team in the Selma Schottenstein Harris Laboratory for Research in Parkinson's Disease at UC will study the potential therapeutic value of two proteins from the neuregulin family of growth factors. Their goal is to identify the best candidate for future preclinical testing. Six national and local Parkinson's disease groups and a charitable trust teamed with the Fox Foundation to award more than $3.6 million to 18 outstanding researchers around the world.
Kenter Receives Prestigious Fellowship
Keith Kenter, MD, assistant professor of sports medicine and shoulder reconstruction in the Department of Orthopaedic Surgery, has received the American Orthopaedic Society for Sports Medicine Traveling Fellowship for 2005. This prestigious academic award will take Dr. Kenter to South America for four weeks of lecturing and teaching in May.
COM Faculty Among Research Council Grant Winners
Six College of Medicine faculty members have been awarded faculty research support grants from the University Research Council. They are Kenneth Clark, PhD, Department of Obstetrics and Gynecology; Angela Drew, PhD, Department of Genome Science; Jeffrey Livingston, MD, Department of Obstetrics and Gynecology; Robert Ludke, MD, Department of Family Medicine, Institute for Health Policy and Health Services Research; Suzanne Numan, PhD, Department of Neurology; and Yiping Wang, PhD, Department of Psychiatry. In all, the University Research Council awarded 23 grants from 1003 applications in the first round of competition for this academic year. View the entire list of grant winners.
Largest Type 2 Diabetes Study Continues at UC
An NIH-sponsored, multi-center Type 2 diabetes clinical trial underway at UC's Academic Health Center and the Cincinnati Veterans Affairs Medical Center, will continue its recruitment of patients through June 2005. ACCORD (Action to Control Cardiovascular Risk in Diabetes), the largest North American Type 2 diabetes research study, is testing whether two different target levels of blood sugar control make a difference in preventing heart attacks and strokes. The study provides expert diabetes care, counseling for a healthy lifestyle, eye exams, lab tests, diabetes and either lipid or blood pressure medications, and glucose testing supplies, all at no cost to the participant. For more information, call 487-6062.
COM, German Researchers Team Up on Radiation Exposure Study
UC and German researchers studying thyroid tumors from victims of the 1986 Chernobyl nuclear reactor accident have identified a new type of genetic damage that appears to be a specific characteristic of radiation exposure. The finding contradicts standard textbook assertions that radiation damage has no characteristic "signature." It's important, the researchers believe, because it could provide a clue to developing a treatment that protects specifically against radiation exposure. The study, led by UC's Yuri Nikiforov, MD, PhD, was a collaboration between the College of Medicine's pathology and internal medicine departments and the Institute of Pathology at the University of Munich. The research team's findings appear in the January edition of the Journal of Clinical Investigation.
Queen City 101
The corrugated metal ash can was patented in 1899 by George Witt, founder of the Cincinnati-based Witt Co.